DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sprycel (Dasatinib) - Current Clinical Trials


Sprycel Related Clinical Trials

Dasatinib in Combination With Revlimid (and Dexamethasone) [Completed]

Evaluating the Safety of Zileuton (Zyflo�) in Combination With Dasatinib (Sprycel�) in Chronic Myelogenous Leukemia [Recruiting]

Dasatinib and Crizotinib in Advanced Cancer [Recruiting]

Phase I/II - Dasatinib and Decitabine [Recruiting]

Study of Dasatinib (BMS-354825) in Patients With Solid Tumors [Completed]

Ruxolitinib or Dasatinib With Chemotherapy in Patients With Philadelphia Chromosome (Ph)-Like Acute Lymphoblastic Leukemia (ALL) [Recruiting]

A Trial of Dasatinib (PDGFR and SRC Inhibitor), Temsirolimus and Cyclophosphamide in Patients With Advanced Solid Tumors [Not yet recruiting]

A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC [Active, not recruiting]

Ph I Dasatinib + Erlotinib in Recurrent MG [Completed]

Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer [Completed]

Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia [Terminated]

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma [Terminated]

Effects of Gastric pH on the Pharmacokinetics of Dasatinib [Completed]

PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Completed]

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies [Recruiting]

Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies [Active, not recruiting]

XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib [Completed]

Pharmacokinetic Study Comparing Blood Levels of Dasatinib in Healthy Participants Who Received the Tablet Formulation With Those Who Received Liquid and Tablet-dispersed Formulations [Completed]

Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer [Terminated]

Dasatinib in Resectable Malignant Pleural Mesothelioma [Active, not recruiting]

Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia [Active, not recruiting]

Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory Disease [Recruiting]

Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC [Terminated]

Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer [Terminated]

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 [Active, not recruiting]

Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer [Completed]

Explore the Synergy of Combination TKI Therapy [Withdrawn]

Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) [Completed]

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer [Completed]

Study of Erlotinib in Combination With Dasatinib [Completed]

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) [Recruiting]

Gemcitabine and Dasatinib in Advanced Solid Tumors [Completed]

Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate [Terminated]

First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL [Completed]

Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study [Recruiting]

Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma [Recruiting]

Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma [Terminated]

Phase II Dasatinib Study in Advanced Breast Cancer [Completed]

Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation [Terminated]

Trial of Dasatinib (Sprycel�) in Subjects With Hormone-refractory Prostate Cancer [Completed]

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery [Completed]

A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma [Completed]

Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL) [Active, not recruiting]

Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer [Completed]

Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia [Active, not recruiting]

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML [Completed]

Study of Dasatinib in Patients With Chronic Myelogenous Leukemia [Active, not recruiting]

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia [Completed]

Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) [Completed]

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) [Completed]

A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia [Active, not recruiting]

Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia [Withdrawn]

Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis [Active, not recruiting]

A Phase I/II Study of Dasatinib and Dacarbazine [Completed]

FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer [Active, not recruiting]

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923) [Active, not recruiting]

Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma [Recruiting]

Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Recruiting]

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan [Completed]

Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML [Completed]

A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib [Not yet recruiting]

Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia [Recruiting]

A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) [Recruiting]

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic [Completed]

A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) [Terminated]

Study of Dasatinib in Patients With Advanced Solid Tumors [Terminated]

Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts [Completed]

Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma [Active, not recruiting]

Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma [Recruiting]

A Phase II Evaluation of Dasatinib (Sprycel, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma [Completed]

Safety Study of Dasatinib With Bortezomib (Velcade) and Dexamethasone for Multiple Myeloma [Terminated]

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor [Completed]

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia [Completed]

Hyper-CVAD Plus Dasatinib in Philadelphia/BCR-ABL Positive ALL [Active, not recruiting]

Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic [Recruiting]

Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome [Recruiting]

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [Active, not recruiting]

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery [Terminated]

Rollover Study of BMS-354825 in Patients With CML and Ph+ALL [Completed]

The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects [Completed]

A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia [Completed]

Dasatinib in Relapsed Chronic Lymphocytic Leukemia [Completed]

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer [Completed]

Dasatinib in Treating Patients With Metastatic Pancreatic Cancer [Completed]

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer [Suspended]

Solid Tumors Using Ixabepilone and Dasatinib [Completed]

Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Completed]

Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery [Terminated]

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer [Terminated]

Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer [Completed]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017